Northwest Biotherapeutics Market Cap

Northwest Biotherapeutics has a market cap or net worth of $365.56 million as of November 15, 2024. Its market cap has decreased by -58.94% in one year.

Market Cap

365.56M

Enterprise Value

436.83M

Revenue

1.60M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.28

Market Cap Chart

Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 365.56M, an increase of 3,452.81%. That is a compound annual growth rate of 16.84%.

Market Cap History

Date	Market Cap	% Change
Nov 14, 2024	376.06M	-54.24%
Dec 29, 2023	821.84M	-1.00%
Dec 30, 2022	830.10M	25.14%
Dec 31, 2021	663.34M	-47.13%
Dec 31, 2020	1.25B	870.89%
Dec 31, 2019	129.23M	20.18%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sandoz Group AG	19.44B
Telix Pharmaceuticals Limited	4.97B
Elekta AB (publ)	2.22B
Ryman Healthcare Limited	1.93B
Verano Holdings Corp.	644.39M
Vireo Growth Inc.	110.67M
Medexus Pharmaceuticals Inc.	35.71M

Market Cap Rankings